Virtual music-based relaxation for anxiety in young cancer survivors
Determining the Feasibility of Virtual, Tailored, Music-Based Relaxation for Anxiety in Adolescent and Young Adult Cancer Survivors
This study is testing a virtual music-based relaxation program to see if it can help young cancer survivors with anxiety feel better over eight weeks.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 15 Years to 39 Years |
| Sex | All |
| Sponsor | University of Michigan Rogel Cancer Center Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Ann Arbor, Michigan) |
| Trial ID | NCT05911269 on ClinicalTrials.gov |
What this trial studies
This intervention aims to assess the feasibility of an eight-week, tailored music-based relaxation program delivered virtually to reduce anxiety in adolescent and young adult cancer survivors. Participants will engage in 45-minute sessions each week, with the final session allowing for participant selection of activities to enhance personalization. The study targets individuals who have completed cancer treatment and report clinically relevant anxiety, utilizing a structured approach to measure outcomes. The intervention is designed to be accessible and adaptable to the needs of the participants.
Who should consider this trial
Good fit: Ideal candidates are adolescents and young adults aged 15 to 39 who are at least one month post-cancer treatment and report clinically relevant anxiety.
Not a fit: Patients with a prognosis of less than three months or those planning to start new anxiety treatments during the study may not benefit from this intervention.
Why it matters
Potential benefit: If successful, this intervention could provide a novel, accessible method for reducing anxiety in young cancer survivors.
How similar studies have performed: While the specific approach of tailored music-based relaxation is novel, similar interventions targeting anxiety in cancer survivors have shown promise in previous studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 15 - 39 years old * at least one month post cancer treatment * report clinically relevant anxiety in the past seven days (PROMIS Anxiety 4a scores ≥ 55)35 * speak/read English. Exclusion Criteria: * prognosis less than 3 months * documentation of significant hearing impairment * plan to receive surgery, radiation, or chemotherapy for cancer treatment during the study period * plans in place to begin new psychosocial (i.e., cognitive behavioral therapy14 or mindfulness-based stress reduction15) or pharmacological treatments for anxiety during the study. Although, participants may continue psychosocial or pharmacological treatments for anxiety if the treatments were initiated at least eight weeks prior to study enrollment, the dose has not changed, and they report clinically relevant anxiety in the last week.
Where this trial is running
Ann Arbor, Michigan
- University of Michigan — Ann Arbor, Michigan, United States (Recruiting)
Study contacts
- Principal investigator: Robert Knoerl — University of Michigan Rogel Cancer Center
- Study coordinator: Robert Knoerl
- Email: rjknoerl@med.umich.edu
- Phone: 734-764-8617
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.